Invesaro

Stocks Health care CAH

NYSE · Health care

Cardinal Health Inc (CAH)

Cardinal Health Inc reported revenue of $254.2B in fiscal 2026, up 14.2% from a year earlier. Net income was $1.7B, a net margin of 0.7%. Operating cash flow minus capital spending left $4.5B of free cash flow in fiscal 2026. At June 30, 2026 it held $4.9B in cash against $8.9B of debt. Its latest periodic report to the SEC is the annual report (10-K) filed on August 11, 2026.

Price
$233.12
+2.11% on the day · October 5, 2026
52-week range $151.87 to $258.30
Market cap
$54.2B
Revenue (FY2026)
$254.2B
+14.2% year on year
Net margin
0.7%
P/E
32.2
on FY2026 diluted EPS

Key facts about Cardinal Health Inc

Net worth
Cardinal Health Inc has a market value (market cap) of $54.2B at the latest share price, and shareholders' equity of -$2.9B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $254.2B (+14.2% year on year), with net income of $1.7B.
Cash flow
In fiscal 2026 operations brought in $5.2B of cash; after $649M of capital spending, free cash flow was $4.5B.
Latest report
The latest periodic report (annual report, 10-K) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Cardinal Health Inc's next report is expected around October 29, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
Cardinal Health Inc paid dividends of $2.04 per share in fiscal 2026, a yield of 0.88% at the current price.

What Cardinal Health Inc does

Cardinal Health distributes pharmaceuticals, medical products, and laboratory supplies to pharmacies, hospitals, clinics, and other healthcare facilities. It also manufactures medical and surgical products for clinical use. Its shares trade on NYSE under the ticker CAH.

Revenue and profit by year

Revenue
FY19: $145.5B $145.5B FY19FY20: $152.9B $152.9B FY20FY21: $162.5B $162.5B FY21FY22: $181.3B $181.3B FY22FY23: $205B $205B FY23FY24: $226.8B $226.8B FY24FY25: $222.6B $222.6B FY25FY26: $254.2B $254.2B FY26
Net income
FY19: $1.4B $1.4B FY19FY20: -$3.7B -$3.7B FY20FY21: $611M $611M FY21FY22: -$938M -$938M FY22FY23: $330M $330M FY23FY24: $852M $852M FY24FY25: $1.6B $1.6B FY25FY26: $1.7B $1.7B FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$254.2B$2.6B$1.7B$7.23$4.5B
2025$222.6B$2.3B$1.6B$6.45$1.9B
2024$226.8B$1.2B$852M$3.45$3.3B
2023$205B$752M$330M$1.26$2.4B
2022$181.3B-$607M-$938M-$3.37$2.8B
2021$162.5B$472M$611M$2.08$2B

Full financial statements: income, balance sheet and cash flow

Next report expected around October 29, 2026.

Estimated from its filing rhythm: 52 weeks after its report of October 30, 2025. Not a date the company has announced. See the report calendar

Where CAH ranks in Health care

Revenue$254.2B
#5 of 750 in Health care · Top 1%
Revenue growth+14.2%
#235 of 532 in Health care · Top 44%
Net margin0.7%
#213 of 543 in Health care · Top 39%
Free cash flow margin1.8%
#221 of 489 in Health care · Top 45%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Cardinal Health Inc paid $2.04 per share in fiscal 2026. At the current price that is a yield of 0.88%. It paid out $491M in cash dividends, 29% of its net income.

Fiscal yearPer sharePaid outOf profit
2026$2.04$491M29%
2025$2.02$494M32%
2024$2.00$499M59%
2023$1.98$525M159%
2022$1.96$559Mn/a
2021$1.94$573M94%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Cardinal Health Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 1, 2026
  2. September 21, 2026
  3. September 21, 2026
  4. September 21, 2026
  5. August 13, 2026
  6. August 11, 2026
    Annual report 10-K · period to June 30, 2026Revenue rose 14% to $254.2B versus the prior year; diluted EPS $7.23 versus $6.45.
  7. August 11, 2026
  8. August 11, 2026
  9. August 5, 2026
  10. June 23, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 20, 2026. Insider transactions on SEC

What is CAH worth? A DCF from its reported cash flow

Insider trades

What the people running Cardinal Health Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $59.6M worth of shares in the last 90 days and bought none on the open market.

Bought (open market)
$0
last 90 days
Sold
$59.6M
last 90 days
Net sold
252,271
$59.6M
DateInsiderWhatSharesPriceValueFiling
August 19, 2026 Hollar Jason M.Chief Executive Officer Sold 6,206 $233.22 $1.4M Form 4
August 19, 2026 Hollar Jason M.Chief Executive Officer Sold 3,457 $234.29 $809.9K Form 4
August 19, 2026 Hollar Jason M.Chief Executive Officer Sold 5,704 $235.34 $1.3M Form 4
August 19, 2026 Hollar Jason M.Chief Executive Officer Sold 6,731 $236.46 $1.6M Form 4
August 19, 2026 Hollar Jason M.Chief Executive Officer Sold 16,187 $237.23 $3.8M Form 4
August 19, 2026 Hollar Jason M.Chief Executive Officer Sold 6,244 $237.88 $1.5M Form 4
August 19, 2026 Scherer Mary C.Chief Accounting Officer Sold 100 $237.40 $23.7K Form 4
August 19, 2026 Scherer Mary C.Chief Accounting Officer Sold 2,202 $237.39 $522.7K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CAH

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Vanguard Capital Management13G, passive 7.49% 17,635,857 April 29, 2026
Wellington Management Group LLP13G, passive with 3 related filers 6.3% 14,860,271 August 13, 2026
Vanguard Portfolio Management13G, passive 5.85% 13,786,683 April 29, 2026

Latest filings below 5%: The Vanguard Group 0% (March 26, 2026); BlackRock Portfolio Management LLC 3.8% (January 21, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1,496 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.26,490,633$6.29B-2,004,222
Vanguard Capital Management LLC15,292,186$3.63B+3,477
Wellington Management Group Llp14,860,271$3.53B+10,584,119
Vanguard Portfolio Management LLC13,717,894$3.26B-14,415
State Street Corp11,967,121$2.84B-107,397
Geode Capital Management, LLC6,472,810$1.53B-107,722
Invesco Ltd.4,742,576$1.13B+1,230,335
Morgan Stanley4,625,329$1.1B-328,999
Wcm Investment Management, LLC4,112,461$971.4M+105,825
Norges Bank3,726,422$885.2Mnew
Bank of America Corp2,900,596$689.1M+18,831
Northern Trust Corp2,868,903$681.5M+74,596
Jpmorgan Chase & Co2,668,749$630.4M+352,105
Goldman Sachs Group Inc2,385,033$566.6M+13,179
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2,224,578$528.5M-97,860
Bnp Paribas Financial Markets2,103,149$499.6M+599,252
Fmr LLC2,066,248$490.9M-2,176,992
Victory Capital Management Inc1,977,579$469.8M+590,745
Legal & General Group Plc1,847,406$438.9M-192,520
Aqr Capital Management LLC1,732,808$411.6M+143,038

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

20 insiders reported holding 577,636 shares in total, about $134.7M at the last price.

HolderSharesAs of
Hollar Jason M.Chief Executive Officer 190,603 August 19, 2026
Weitzman DeborahCEO, PSS Segment 77,901 August 18, 2026
Kenny Gregory BDirector 64,194 November 5, 2025
Mayer Jessica LChief Legal/Compliance Officer 33,076 August 18, 2026
Hall Patricia HemingwayDirector 28,645 April 15, 2026
Killefer NancyDirector 27,624 November 5, 2025
Johri AkhilDirector 22,868 November 5, 2025
Alt Aaron EChief Financial Officer 20,495 August 18, 2026
Mason Stephen MCEO, GMPD Segment 18,061 August 18, 2026
Evans David CDirector 15,373 November 5, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CAH

What does Cardinal Health Inc do?

Cardinal Health distributes pharmaceuticals, medical products, and laboratory supplies to pharmacies, hospitals, clinics, and other healthcare facilities. It also manufactures medical and surgical products for clinical use. Its shares trade on NYSE under the ticker CAH.

What is Cardinal Health Inc's net worth?

Cardinal Health Inc has a market value (market cap) of $54.2B at the latest share price, and shareholders' equity of -$2.9B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Cardinal Health Inc profitable?

Yes. In fiscal 2026 it reported net income of $1.7B on revenue of $254.2B, a net margin of 0.7%.

How much revenue does Cardinal Health Inc make?

In fiscal 2026 Cardinal Health Inc reported revenue of $254.2B. That is 14.2% more than a year earlier.

When did Cardinal Health Inc last report?

Its most recent periodic report is the annual report (10-K) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from October 1, 2026.

When is Cardinal Health Inc's next earnings report?

Cardinal Health Inc's next report is expected around October 29, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Does Cardinal Health Inc pay a dividend?

Yes. Cardinal Health Inc paid dividends of $2.04 per share in fiscal 2026, a yield of 0.88% at the current price.

Similar companies

Compare CAH with

Compare CAH with any company

Follow CAH

Get an email when Cardinal Health Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow CAH: get an email when it files

Where the numbers come from

Financial figures are the values Cardinal Health Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.